Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology (Q46253129)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology |
scientific article |
Statements
1 reference
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology (English)
1 reference
Constantin Yiannoutsos
1 reference
Nasser Hanna
1 reference
Marcus Neubauer
1 reference
Ronald McGarry
1 reference
James Arseneau
1 reference
Rafat Ansari
1 reference
Craig Reynolds
1 reference
Ramaswamy Govindan
1 reference
Anton Melnyk
1 reference
William Fisher
1 reference
Donald Richards
1 reference
Daniel Bruetman
1 reference
Thomas Anderson
1 reference
Naveed Chowhan
1 reference
Sreenivasa Nattam
1 reference
Prasad Mantravadi
1 reference
Cynthia Johnson
1 reference
Tim Breen
1 reference
Angela White
1 reference
Lawrence Einhorn
1 reference
Hoosier Oncology Group
1 reference
US Oncology
1 reference
10 November 2008
1 reference
26
1 reference
35
1 reference
5755-5760
1 reference